WallStreetZenWallStreetZen

AnalystsEmmanuel Papadakis
Emmanuel Papadakis's Stock Forecasts

Analyst Ranking
Top 30%
#1223 out of 4126 analysts
Average Return
+6.06%
Win Rate
67%6 out of 9
Risk vs Reward
Poor
Good

Emmanuel Papadakis's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Novo Nordisk A SNVO
+33.72%$72.03$96.32
2021-01-15 -
2022-01-14
Strong Buy
Moderna IncMRNA
+29.07%$141.28$182.35
2022-09-08 -
2022-12-02
Strong Buy
Novo Nordisk A SNVO
+19.45%$106.24$126.90
2022-03-16 -
2022-12-02
Strong Buy
Astrazeneca PLCAZN
+14.63%$51.34$58.85
2021-01-15 -
2022-01-14
Strong Buy
Novartis AgNVS
+2.50%$82.80$80.73
2021-09-20 -
2022-09-19
Strong Sell

Emmanuel Papadakis's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Moderna IncMRNA
3Strong Buy$165.00-9.51%Upgrades
3 months ago
SanofiSNY
3HoldN/AN/AUpgrades
4 months ago
AlvotechALVO
1Hold$10.00+57.23%Initiates Coverage On
5 months ago
Novo Nordisk A SNVO
2Strong BuyN/AN/AUpgrades
9 months ago
Grifols SaGRFS
1HoldN/AN/ADowngrades
a year ago
Biontech SeBNTX
1Hold$250.00N/AInitiates Coverage On
a year ago
Curevac NvCVAC
1Hold$35.00N/AInitiates Coverage On
a year ago
Novartis AgNVS
4Strong SellN/AN/ADowngrades
a year ago
Argenx SeARGX
1HoldN/AN/AInitiates Coverage On
a year ago
Ucb SaUCBJY
1Strong BuyN/AN/AInitiates Coverage On
a year ago
Roche Holding LtdRHHBY
1Strong BuyN/AN/AUpgrades
a year ago
Gsk PLCGSK
2Strong SellN/AN/ADowngrades
2 years ago
Astrazeneca PLCAZN
1Strong BuyN/AN/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.